Sjoerd Rijpkema sees merit in the amendment to the Opium Act, but at the same time believes that this is only one side of the coin.

Opiumwet1

From 1 July 2025, the entire group of NPS (new psychoactive substances) will be banned. For the first time, a complete class of chemicals sharing the same base structure will fall under the Opium Act. Politicians are calling this a clever way to stay ahead of designer drug development. At present, designer drugs are something of a hydra: ban 4-MMC, and 3-MMC and 2-MMC pop up in its place.

The government has a point: those new variants are often impure, less potent and barely tested, which increases the risks. A group-wide ban makes sense. However, in doing so you simultaneously push more money into the illegal circuit. So why not also begin legalising the mainstream drugs upon which these imitations are based?

LSD, MDMA, psilocybin: an enormous amount is already known about their effects, safety and dosage — provided you know where to look. What’s more, many of these substances are demonstrably safer than alcohol. MDMA-assisted psychotherapy shows great promise in treating PTSD. And even recreationally, users know perfectly well what they’re doing — just ask the next festival-goer wandering past with pupils in night-vision mode.

Ban the rubbish that circumvents legislation and goes untested, but legalise the substances whose effects we’ve understood for a long time. Dr Hofmann cycled into the future in 1943. It’s time to get back in the saddle.

 
Sjoerd Rijpkema
Sjoerd Rijpkema 11 June 2025

No comments yet

More Opinion
Human Errors
25 May 2026 — Enith Vlooswijk
Knowledge Transfer
12 May 2026 — Jenny Hasenack
Ice lollies
04 May 2026 — Sjoerd Rijpkema
Vocation
21 Apr 2026 — Esther Thole
C2Weekly nieuwsbrief
weekly

Don't miss a single update with our C2Weekly newsletter

Every Wednesday in your inbox: the latest chemistry and life sciences news from the Netherlands and Flanders, plus analyses, background stories and more!

Log in

Not registered yet?

Register for free to receive the newsletter, create your own profile, and comment on our articles.

Not registered yet?

Register for free and receive our newsletter.

Login for members of KNCV, KVCV, NBV, and NVBMB

  • Log in using the email address registered with your association. If you are unsure which email address to use, please check the address where you receive your association’s digital newsletter.
  • If you have not logged in before, you must create a new password. To do this, click “reset password”.